{"schema_version":"secwatch.filing_event.v1","accession":"0001664710-26-000003","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.805733+00:00","generated_at":"2026-05-16T11:04:22.844354+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Keros Therapeutics corporate presentation highlights Phase 2 data and cash runway into 2028","bullets":["Phase 2 KER-050 in lower-risk MDS: 45% RBC transfusion independence at 24 weeks (ASH Dec 2025).","Phase 2 KER-012 in PAH met primary endpoint: 35m improvement in 6-min walk distance at 24 weeks.","Cash, equivalents and short-term investments of $367.4M as of Sep 30, 2025, funding operations into 2028.","Upcoming milestones: KER-050 higher-risk MDS data mid-2026; KER-012 HFpEF trial start H1 2026; KER-065 Phase 1 data H1 2026.","No new financing, leadership changes, or material agreements disclosed in the update."],"urls":{"canonical":"https://secwatch.observer/filing/0001664710-26-000003","json":"https://secwatch.observer/filing/0001664710-26-000003.json","markdown":"https://secwatch.observer/filing/0001664710-26-000003.md","text":"https://secwatch.observer/filing/0001664710-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000003/0001664710-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000166471026000003/kros-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:04:22.844354+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}